VISIONS Magazine (February March 2026 Edition)
From Collaboration to Strategic Investment: Strengthening a Partnership with Fusion Innovator SHINE Technologies
In April 2025, Sumitomo Corporation of Americas (SCOA) and Wisconsin-based SHINE Technologies (SHINE) announced a strategic partnership designed to expand the reach of fusion-derived technologies, particularly medical isotopes and neutron imaging services, into Japan and other Asian markets. The agreement, formalized through a Memorandum of Understanding (MOU), focused on exploring supply chains and distribution pathways for emerging technologies that combine advanced nuclear science with practical industrial and medical applications.
Less than a year later, that collaboration has moved into a new phase.
SCOA has announced an investment in SHINE, strengthening the relationship and positioning both companies to accelerate the commercialization of fusion-derived applications while advancing the longer-term goal of fusion energy development. The investment builds directly on the work initiated under the earlier MOU and signals a deepening commitment to collaboration across multiple technology areas.
The shift from exploratory partnership to equity participation reflects the growing strategic alignment between the two organizations as SHINE continues expanding its portfolio of commercial technologies.
From Strategic Exploration to Equity Partnership
Headquartered in Janesville, Wisconsin, SHINE has taken a distinctive approach to fusion innovation. While many companies in the sector focus primarily on long-term fusion power generation, SHINE has built a business model around fusion-derived applications that can be commercialized today.
These include medical isotopes used in disease diagnosis and treatment, neutron imaging technologies used in advanced industrial inspection, and irradiation services that support materials research and quality assurance across a range of industries.
These applications formed the foundation of the 2025 MOU between SHINE and SCOA, which aimed to explore opportunities to distribute SHINE’s products and services in Japan and other Asian markets. The collaboration focused on developing reliable supply chains for critical medical isotopes and other specialized technologies while studying the regulatory and logistical requirements associated with transporting radioisotopes internationally.
With the new investment, Sumitomo Corporation Group is strengthening that collaboration by transitioning the relationship into a strategic partnership supported by equity participation. “From our perspective, this investment represents a strategically important step in advancing EIIA by evolving our collaboration with SHINE from an exploratory phase into a long-term, value-driven partnership,” said Tsutomu Sakamoto, General Manager of Energy Innovation Initiative Americas (EIIA) at SCOA. With the new investment, Sumitomo Corporation Group is strengthening that collaboration by transitioning the relationship into a strategic partnership supported by equity participation.Expanding Medical and Industrial Applications
The strengthened partnership reflects the growing commercial momentum behind several of SHINE’s core technologies.
“Building on the achievements of our MOU, the equity investment enables deeper alignment at both the strategic and executive levels, while enhancing our visibility into SHINE’s commercialization processes and pipeline of fusion-derived applications,” Sakamoto said. “This includes near- to medium-term applications such as medical isotopes and neutron imaging, where commercialization is already progressing.”
Among SHINE’s most significant commercial activities is the production of medical isotopes used in modern nuclear medicine.
Radioisotopes such as molybdenum-99 and lutetium-177 play an essential role in diagnosing and treating diseases, including heart disease and cancer. As global healthcare systems increasingly adopt targeted radiopharmaceutical therapies, demand for reliable supplies of these materials has grown significantly.
pictured above: SHINE's Fusion-Driven Subcritical (FDS) system, sometimes called an accelerator-driven fusion neutron source
At the same time, SHINE has developed neutron imaging capabilities that enable high-precision, non-destructive testing of complex materials and components. Neutron imaging allows engineers and researchers to examine internal structures in ways that complement traditional X-ray imaging, making it particularly valuable in aerospace, advanced manufacturing, and defense applications.
“This partnership significantly strengthens SCOA’s role by positioning us as a bridge between SHINE’s advanced fusion-derived technologies and markets where demand and commercialization potential are rapidly expanding,” Sakamoto said. “Through this investment, we gain enhanced access to SHINE’s business development pipeline, closer executive-level engagement, and the ability to share strategic planning insights that directly support commercialization efforts. In practical terms, this allows us to accelerate the expansion of medical isotope production and neutron imaging services—applications that address critical needs in healthcare, aerospace, and defense.”
With a particular focus on Japan and other Asian markets, SCOA can leverage the broader Sumitomo Corporation Group’s global network and commercialization expertise to help strengthen supply chains and support adoption of these technologies across multiple industries.
Building the Foundations of a Fusion Ecosystem
For Sumitomo Corporation Group, the investment also aligns with a broader long-term strategy centered on the development of fusion energy and the industrial ecosystem needed to support it.
Fusion occurs when light atomic nuclei combine to form heavier nuclei, releasing large amounts of energy in the process. Because fusion reactions do not emit greenhouse gases and rely on widely available fuel sources, many scientists view fusion as a potential next-generation baseload energy source. However, achieving commercial fusion power requires far more than laboratory breakthroughs. It requires the development of a complex industrial ecosystem involving advanced materials, fuel cycles, specialized equipment, and global supply chains.
“Looking ahead, we see this investment as a core component of our broader fusion ecosystem strategy,” Sakamoto said. “The realization of fusion energy will require a robust and interconnected ecosystem spanning materials, fuel cycles, advanced equipment, and a wide range of related services. Our approach is to build that ecosystem step by step, beginning with fusion-derived applications that can be commercialized in the near to medium-term.”
“SCOA’s role is to help organically connect technology, industry, and markets by leveraging not only capital, but also our global network, cross-industry expertise, and experience in large-scale commercialization,” Sakamoto added.
pictured above: The Heliopolis campus in Fitchburg, Wisconsin, houses SHINE's systems and manufacturing division, where fusion systems are designed, built and tested.
Connecting Present Applications to Future Energy
For SHINE, the strengthened partnership provides access to a global commercial network capable of accelerating international expansion. For Sumitomo Corporation, the investment reinforces its position within one of the most promising technology sectors of the coming decades.
“By supporting SHINE’s current growth in areas such as medical isotopes and neutron imaging, while remaining engaged in its longer-term fusion energy ambitions, we aim to accelerate the development of an industrial foundation that will ultimately support the social implementation of fusion energy,” Sakamoto said.
While the ultimate goal of commercial fusion power remains years away, fusion-derived applications such as medical isotope production and neutron imaging are already demonstrating the practical potential of the technology.
By expanding these applications and building the industrial networks needed to support them, the partnership between Sumitomo Corporation Group and SHINE represents another step toward a future in which fusion technologies play an increasingly important role in both global industry and energy systems.
